Skip to main content
Clinical Trials/JPRN-UMIN000028855
JPRN-UMIN000028855
Recruiting
Phase 2

Development of a new transcranial magnetic stimulation therapy for treatment-resistant depression and identification of its predictor of response - Development of a new form of rTMS treatment for TRD

Department of Neuropsychiatry, Keio University School of Medicine0 sites150 target enrollmentJanuary 19, 2018

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Treatment-resistant depression(TRD)
Sponsor
Department of Neuropsychiatry, Keio University School of Medicine
Enrollment
150
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
January 19, 2018
End Date
March 31, 2023
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Department of Neuropsychiatry, Keio University School of Medicine

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • (1\) Persons with cerebral organic diseases (e.g., intracranial organic lesions of moderate severity or higher, neurodegenerative diseases, etc.) (2\) History of convulsive seizures or epilepsy (3\) Substance\-related disorders in the past 6 months (4\) Serious or unstable physical illness (5\) Undergone rTMS treatment or ECT within the past 6 months (6\) Any contraindication to TMS or MRI procedures such as metal implants, pacemakers, claustrophobia, etc. (7\) Patients whose head, neck, or body size is not suitable for MRI scanner (8\) Other cases that the principal investigator and subinvestigators deem inappropriate as research subjects

Outcomes

Primary Outcomes

Not specified

Similar Trials